Antifungal drug susceptibility of Candida albicans.

@article{Bii2002AntifungalDS,
  title={Antifungal drug susceptibility of Candida albicans.},
  author={Christine C. Bii and Tom T. Ouko and Evans Inyangala Amukoye and L W Githinji},
  journal={East African medical journal},
  year={2002},
  volume={79 3},
  pages={143-5}
}
OBJECTIVE To determine the susceptibility of clinical isolates of Candida albicans and to establish the minimum inhibitory concentrations (MIC) to commonly used antifungal drugs. DESIGN Laboratory based experiment. SETTING Mbagathi District Hospital, Nairobi, Kenya. SUBJECTS Candida albicans isolated between 1998 and 2000 from the sputa of HIV/AIDS patients and throat swabs of children with acute respiratory infections (ARI). METHODS Susceptibility to amphotericin B, clotrimazole… CONTINUE READING